WAO warmly invites you to the XXIV World Allergy Congress, the biennial Congress of the World Allergy Organization (WAO), in Seoul, Korea, 14 ? 17 October 2015 to participate in this global scientific event on allergy, asthma and clinical immunology.
ProteomeTech is a biotech company developing immuno-diagnostic products and providing
proteomics-based R&D services.
We have accumulated proteomics-related technologies since 2000.
ProteomeTech has several innovative IVD products; PROTIA Allergy-Q, allergy test detecting
up to 64 allergies in one panel; ImmuneCheck IgG, Human IgG test adopting our own
Q-Rapid Technology can get semi-quantitative results; DoubleCheck, pregnancy test with
Q-Rapid Technology makes more accurate results possible.
up to 64 detecting lines in one plate!
? PROTIA Allergy-Q Inhalant panel/Food panel/Atopy panel
? PROTIA Allergy-Q 64 Food panel/Inhalant panel
? Multiplex, semi-quantitative detection of allergen-specific IgE in human serum or plasma
? 44 or 60 allergens test in a single panel
? Small sample volume: 50 μL
? Time for a test run: approx. 2.5 hours
? Internal calibration lines
? Concordance with ImmunoCap: 96%
? ISO13485, CE certificate
? associated immunoblot devices: Q-Scan(manual), Q-Station(all automation)
-PLA(Paralle Lines Array) Technology
Put more marker lines in a smaller chip by parallel line array
- biochip-assays more efficient & convenient
- Applicable to many kinds of biochip products using line-type blotting
Now with this innovative rapid kit, hIgG level check is fast and easy!
-Model: ImmuneCheck IgG
? Quantitative Rapid test of total IgG for general immunity check-up
? Sample type: Whole blood, Plasma or Serum
? Sample Volume: 2~5 uL
? Assay Time: 20 min
? Good agreement with a Standard Method (Roche Cobas Integra 800)
? Detecting human IgG level 0.12~4000mg/dL
? CE, ISO13485 certificate
-Q-Rapid AD(Quantitative Rapid Test Technology with
Alternative Detection Lines):
This technology overcomes the hook effect by having two assay method lines
(sandwich immunoassay line and competitive immunoassay line) in a single test.
It also makes quantitative detection possible for rapid kit. ProteomeTech owned, patent applied.